end-stage renal disease
Conditions
Interventions
ESKD group:Ciprofol
Sponsors
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: (1) ESKD group: Those who with end-stage renal disease underwent elective kidney transplantation for the first time; control group: Those who underwent elective general anesthesia with normal renal function; (2) Choose a supraglottic airway management tool such as the laryngeal mask; (3) The patient's age is 18-64 years old; (4) Body mass index is 18.5-24.0 kg/m2; (5) ASA classification I-III;
Exclusion criteria
Exclusion criteria: (1) The patients in the ESKD group had severe insufficiency of important organs except the kidneys, and the patients in the control group had severe insufficiency of important organs; (2) Patients who are allergic to anesthetics such as cyclopofol and propofol; (3) Long-term use of psychotropic drugs, severe cognitive and mental disorders; (4) Limited head and neck movement, Mallampati grade III or IV, mouth opening 24.0kg/m2; (6) Participate in other clinical investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ciprofol dosage; | — |
Countries
China
Contacts
Public ContactLi Juan
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Outcome results
None listed